WiseGuyReports.com adds “Point of Care Diagnostics (POCD) Market 2017 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2023”reports to its database.
Pint of care tests, also called near-patient testing or bedside testing, refers to the performance of diagnostic tests at or near the site where the patient is located and helps in obtaining accurate results in a very short period of time. It can be performed by non-laboratory personnel and the main benefit of POCT is to make tests more convenient and immediately to the patient that helps doctors/physician to receive the results quicker, enabling clinicians to support the timely diagnosis, monitoring, and treatment of patients. It can be performed by non-laboratory personnel and the results are used for clinical decision making. POCD is usually used in clinics, healthcare departments, hospitals, and patient’s homes. In hospitals, they are primarily performed in emergency departments, surgical suites, critical care units, and certain outpatient areas. POC tests can be performed by a wide variety of people can, including laboratory professionals, emergency first responders, radiologists, doctors, nurses, physician assistants, or other healthcare practitioners.
They may even be done by patients, sometimes called “self-tests” or “home tests”. POCT has a range of complexity and procedures that vary from manual methodologies to automated analyzers. With the advancements in technology, POC testing analyzers are becoming smaller, faster, and more user-friendly and to achieve accuracy with increasingly smaller samples (body fluids).
The point of care diagnostics global market is expected to grow at single digit CAGR to reach $26,331.1 million by 2023.
The Point of care diagnostics market is segmented based on their products, technology, prescription mode, sample types, end-users, and geography.
The global POCD market by products is segmented into glucose monitoring kits, infectious diseases testing kits, coagulation monitoring kits, hematology testing kits, pregnancy and fertility testing kits, cardiometabolic testing kits, tumor/cancer markers, urinalysis kits, cholesterol testing kits, drugs-of-abuse testing kits and others.
The glucose monitoring kits are further segmented into self-glucose monitoring and continuous glucose monitoring kits.
The Infectious diseases kits are further divided into HIV testing kits, Hepatitis testing kits, Tropical diseases testing kits, tuberculosis testing kits, Healthcare–Associated infection testing kits, respiratory infections testing kits, and others.
The coagulation monitoring testing kits are further segmented into Prothrombin Time(PT/INR) Testing Kits and Activated Clotting Time(ACT/APTT) Testing Kits.
The Pregnancy and Fertility Testing Kits are further segmented into Pregnancy Testing Kits and Fertility Testing Kits. The Cardiometabolic Monitoring Kits further segmented into Cardiac Markers, Blood Gas/Electrolytes Testing Kits, HBA1C Testing Kits, and LIPID Testing Kits. By technology, the POCD market is divided into a biosensor,microfluidics/lab-on-a-chip technology, PCR technology, Immunochromatographic/lateral flow technology and others.Based on prescription mode, POCD market is segmented into prescription based tests and over the counter tests.
By sample types, POCD market is divided into blood, urine, saliva and others. Based on end-users, POCD market is segmented into hospitals, home healthcare, clinics.
Further, the POCD global market is separated by geographical regions into North America, Europe, Asia-pacific and Rest of the World.
Partner Relations & Marketing Manager
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)